![]() |
|
|
Vol. 286, Issue 2, 772-779, August 1998
Laboratory of Pulmonary Pathobiology (J.M.S.P., D.C.Z.),
| |
Abstract |
|---|
|
|
|---|
Epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids,
products of the cytochrome P450 arachidonic acid epoxygenase pathway,
have been shown to affect electrolyte transport in the kidney; however,
the effects of these compounds on airway epithelial ion transport have
not been investigated. Intact rat tracheas and primary cultures of rat
tracheal epithelial cells were mounted in Ussing chambers to monitor
changes in transepithelial voltage (Vt), short circuit current (Isc)
and electrical resistance (Rt), with or without the addition of
increasing concentrations (10
9-10
6 M) of
arachidonic acid, each of the four regioisomeric EETs and each of the
corresponding dihydroxyeicosatrienoic acids. In intact tracheas,
11,12-EET caused dose-dependent decreases in Vt and Isc (
Vt = 0.4 ± 0.1 mV,
Isc =
16.9 ± 5.4 µA/cm2 at 10
6 M, P < .05 vs. vehicle), whereas changes in Rt were not significantly different than vehicle alone. 11,12-dihydroxyeicosatrienoic acid caused
less impressive decreases in Vt and Isc, although arachidonic acid and
the other compounds tested were without significant effects. 11,12-EET
induced similar changes in cultured tracheal epithelial cell electrical
parameters at concentrations as low as 10
9 M. The effects
of 11,12-EET were highly stereoselective, with activity limited to
11(R),12(S)-EET, the least abundant rat lung enantiomer. Pretreatment
with amiloride or mucosal exposure to sodium free media did not
significantly alter the 11,12-EET-induced changes in Vt. In contrast,
pretreatment with bumetanide abolished the 11,12-EET electrophysiologic
effects, suggesting that these effects may be mediated through
inhibition of a chloride conductive pathway. We conclude that
arachidonic acid epoxygenase metabolites cause significant changes in
rat airway electrical parameters and may be involved in the control of
lung fluid and electrolyte transport.
| |
Introduction |
|---|
|
|
|---|
AA,
a 20-carbon polyunsaturated fatty acid, is normally found esterified to
cell membrane glycerophospholipids. In response to several stimuli, AA
can be released from these cellular pools by phospholipases and can
serve as a precursor to several biologically active compounds. The
three major enzymatic pathways for AA oxidation are the cycloxygenase
pathway, the lipoxygenase pathway and the cytochrome P450 monoxygenase
pathway (Capdevila et al., 1992
, 1995
; Fitzpatrick and
Murphy, 1989
; McGiff, 1991
). In the cycloxygenase pathway, PGH
synthases generate PGH2, which can be further metabolized into other PG, thromboxane and prostacyclin. The lipoxygenases generate
HPETEs, which are converted to leukotrienes and HETEs. Cytochrome P450
monoxygenases generate four regioisomeric epoxyeicosatrienoic acids
(5,6-, 8,9-, 11,12- and 14,15-EET), several mid-chain
cis,trans-conjugated dienols (HETEs), and
/
-1 alcohols
of AA (19-OH-AA and 20-OH-AA) (Capdevila et al., 1992
, 1995
;
Fitzpatrick and Murphy, 1989
; McGiff, 1991
). EETs are further
metabolized by epoxide hydrolases to four regioisomeric
dihydroxyeicosatrienoic acids (5,6-, 8,9-, 11,12- and 14,15-DHETs)
(Zeldin et al., 1993
). Both EETs and DHETs have been shown
to influence a variety of biological processes including control of
vascular (Carrol et al., 1987
; Gebremedhin et
al., 1992
; Katoh et al., 1991
) and airway (Zeldin
et al., 1995
) smooth muscle tone, regulation of
pituitary/hypothalamic and pancreatic peptide hormone release (Cashman
et al., 1987
; Falck et al., 1983
; Snyder et
al., 1983
), inhibition of platelet aggregation (Fitzpatrick et al., 1986
; Malcolm and Fitzpatrick, 1992
), and modulation
of fluid and electrolyte transport (Harris et al., 1990
; Hu
and Kim, 1993
; Jacobson et al., 1984
).
Much of what is known about the effects of P450-derived AA metabolites
on ion transport is based on studies in the kidney. For example,
5,6-EET caused an increase in cytosolic calcium (Ca++)
concentration via verapamil-sensitive channels and inhibited mucosal-submucosal sodium (Na+) flux in proximal tubular
cells (Madhun et al., 1991
), and inhibited Na+
reabsorption and potassium (K+) secretion in the cortical
collecting duct (Jacobson et al., 1984
). 14,15-EET activated
Na+/H+ exchange and potentiated
vasopressin-induced changes in cytosolic Ca++ in glomerular
mesangial cells (Force et al., 1991
; Harris et al., 1990
). In addition, several studies have demonstrated that the EETs are active in modulating ion transport in extrarenal tissues.
For example, 14,15-EET decreased calcium uptake in vascular smooth
muscle and platelets (Kutsky et al., 1983
; Malcolm and Fitzpatrick, 1992
), 5,6-EET and 11,12-EET increased intracellular Ca++ in cardiac myocytes (Moffat et al., 1993
),
and all of the EETs activated a Ca++-dependent
K+ channel in portal vein and coronary artery smooth muscle
cells (Hu and Kim, 1993
). Importantly, although AA and prostaglandins have been shown to affect ion transport in tracheal tissue (Eling et al., 1986
; Hwang et al., 1990
; Mochizuki
et al., 1992
; Van Scott et al., 1990
), the role
of P450-derived eicosanoids on airway epithelial cell electrical
parameters has not been investigated.
Cytochrome P450 monooxygenases are present in lung tissue of different
species including rat, rabbit, guinea pig and humans (Gonzalez et
al., 1992
; Knickle and Bend, 1994
; Nhamburo et al., 1989
; Zeldin et al., 1995
, 1996
). Previous
immunohistochemical studies have demonstrated that nonciliated
bronchiolar (Clara) cells contain the highest levels of P450 proteins
(Domin et al., 1986
; Serabjit-Singh et al., 1980
,
1988
; Strum et al., 1990
). Recently, our laboratory has
found that CYP2J subfamily P450s are: 1) highly expressed in human and
rat lung tissue; 2) primarily present in ciliated and nonciliated
epithelia and 3) able to metabolize AA to EETs (Wu et al.,
1996
; Zeldin et al., 1996
). Furthermore, both EETs and DHETs
are present in vivo in lung homogenates and in
bronchoalveolar lavage fluid (Zeldin et al., 1995
, 1996
).
Given the potent effects of EETs on electrolyte transport in
extrapulmonary tissues, we hypothesized that these P450-derived AA
metabolites were active in controlling ion transport in the lung. Thus,
the purpose of this study was to: 1) evaluate the effects of these lung-derived EETs and DHETs on tracheal electrophysiological
properties; 2) investigate for regio- and stereoselectivity of such
effects and 3) begin to understand the mechanisms involved.
| |
Methods |
|---|
|
|
|---|
Materials. All studies used male Fisher 344 rats, 8 to 16 wk old, fed ad libitum with NIH-31 rodent food, and allowed free access to water. Animals were handled under an Institutional Animal Care and Use Committee approved protocol. All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO), except sodium pentobarbital (Anpro Pharmaceutical, Arcadia, CA), amiloride (Merck, Sharp & Dome, West Point, PA), adenosine triphosphate (Boehringer Mannheim, Penzberg, Germany), AA (Nu-Chek-Prep, Inc., Elysan, MN), [1-14C]AA (Du Pont-NEN, Wilmington, DE), rat tail collagen (Collaborative Biomedical Products, Bedford, MA), and Vitrogen 100 (Celtrix Labs., Santa Clara, CA). Polyethylene tubing (PE-190) and nylon cell strainers were purchased from Becton Dickinson (Parsippany, NJ). Six well plates were obtained from Costar Co. (Cambridge, MA).
Experiments using segments of IET.
Animals were killed
by i.p. injection of sodium pentobarbital, and the tracheas were
dissected and placed in 37°C DMEM. The distal two-thirds of the
tracheas were separated, longitudinally opened on the ventral side and
mounted in modified Ussing chambers (Ussing and Zerahn, 1951
). The
lucite chambers exposed 7.1 mm2 tracheal surfaces to
separate mucosal (10 ml) and submucosal (10 ml) reservoirs containing
37°C gassed (95% O2, 5% CO2) KBR solution
(in mM: Na+:140, Cl
:120, K+:5.2,
Mg++:1.2, Ca++:1.2,
HCO3
:25,
HPO4
:2.2,
H2PO4
:0.4, Glucose:5.1). The
transepithelial potential difference was measured with a voltage
current clamp (VCC 600, Physiologic Instruments, San Diego, CA),
connected to the mucosal and submucosal solutions by calomel half cells
and 3M KCl-4% agar bridges, with tips closely opposed to the tissue
sample. Constant current pulses (3 µA, 500 msec length, 10-sec
interval) were passed through the samples by Ag-AgCl electrodes and
KBR-4% agar bridges using a pulse generator. A strip chart recorder
(model 3021, Yokogawa Electric Corporation, Yamanashi-Ken, Japan) was
used for measurements Vt. Rt was calculated from the change in voltage
induced by the constant current (42 µA/cm2) pulse. Isc
was calculated by dividing the open circuit (spontaneous) voltage by
the calculated tissue resistance. After the establishment of a
steady-state, as indicated by maintenance of stable Vt readings for at
least 10 min, five 10-µl aliquots of vehicle (100% ethanol) or one
10-µl vehicle aliquot followed by four 10-µl aliquots of increasing
concentrations of one of the test compounds dissolved in vehicle were
added to the mucosal reservoir at 3-min intervals [final concentration
of ethanol 0.1 to 0.5% (v/v), final concentration of test compounds
10
9 M to 10
6 M]. Test compounds included
AA, 5,6-EET methyl ester, 8,9-, 11,12- and 14,15-EETs, 5,6-, 8,9-, 11,12- and 14,15-DHETs. After the addition of each compound, standard
tissue responses were evaluated using mucosal additions of amiloride
(final concentration 10
4 M), isoproterenol (final
concentration 10
5 M) and ATP (final concentration
10
4 M) at 3-min intervals. Variations in the three
parameters (
Vt,
Rt,
Isc) were calculated using the following
values as reference: for vehicle, baseline values were used; for the
test compounds, post-vehicle values were used; for amiloride, the value
after the last addition of test compound was used; for isoproterenol, the plateau value after addition of amiloride was used; for ATP, the
plateau value after addition of isoproterenol was used. Control experiments using [1-14C]EETs and
[1-14C]DHETs demonstrated that test compounds remained
fully soluble in the bathing solution for the duration of the
experiment.
Experiments using isolated RTE cells.
Permeable CMS
were created over polycarbonate plastic disks with 3-mm central
orifices as previously described (Yankaskas et al., 1985
).
Plain disks were sterilized and cleaned by sequential immersion in 70%
ethanol and 30% bleach solutions. Coating was then performed using rat
tail collagen and Vitrogen 100. Coated disks were kept in Ham's F-12
media, containing 50 U/ml of penicillin and 50 µg/ml of streptomycin
(F12/P + S) for at least 24 hr before cells were seeded. RTE cells
were obtained by pronase dissociation as previously described (Wu
et al., 1982
). Briefly, animals were killed by
CO2 asphyxiation. After sternotomy, tracheas were isolated from the surrounding tissues and a small incision was performed at the
cricoid membrane. Polyethylene tubing with a flanged end was used to
cannulate the tracheas and was secured in place with a 2-0 silk suture.
Tracheas were excised, filled with 0.1% Protease XIV/0.001% DNase
solution and left in F12/P + S at 4°C overnight. RTE cells were
flushed out with F12/P + S containing 5% FBS and filtered through
a 70-µm nylon cell strainer to produce a single cell suspension. The
suspension was centrifuged at 1500 rpm for 15 min and cells were
resuspended in 1 ml of F12/P + S/10% FBS. Cells were counted and
viability was assessed by trypan blue dye exclusion. Cells were
accepted for further experiments only if viability was 85% or more.
CMS disks were placed in six-well plates containing 1 ml of F12/P + S/10% FBS per well and the RTE cells were plated at a density of
50,000 cells per disk. After 24 hr the initial media was removed and a
previously described formulation of DMEM:Ham's F12 with retinoic acid
(final concentration 5 × 10
8 M) (Kaartinen et
al., 1993
) was added the submucosal (2 ml) and mucosal (1 ml)
sides. Cell culture media were thereafter changed every other day and
cells were inspected daily under phase-contrast microscopy. Confluence
was usually achieved in 5 to 7 days. Between days 8 and 14, RTE cell
cultures were mounted in modified Ussing chambers and used in three
separate sets of experiments. The chamber set-up was the same in all
groups and was similar to the IET experiments, except that the current
pulse was 1 µA (current density of 14 µA/cm2). To
determine whether the AA epoxide effects on IETs were due to effects on
the epithelia, 11,12-EET, the most active compound identified in the
IET experiments, was added in increasing doses (10
9 to
10
6 M final concentration) to cultured RTE cells. The
standard drugs (amiloride, isoproterenol and ATP) were then added to
the mucosal bathing solution at concentrations used in the IET
experiments. Time control studies recorded data for 12 min, after which
the standard drugs were added. Vehicle control studies recorded data after addition of vehicle alone to the bathing solution, followed by
additions of the standard drugs.
6 M), followed by
addition of standard drugs. The mechanisms of action of the 11,12-EET
effects were evaluated with seven groups of experiments: 1) Time
control: data recording for 3 min, then addition of standard drugs, 2)
Vehicle control: mucosal addition of vehicle [0.02-0.08% (v/v)],
data recording for 3 min, then addition of standard drugs, 3) 11,12-EET
dose-response: mucosal addition of 11,12-EET (10
9 to
10
6 M), data recording for 3 min, then addition of
standard drugs. 4) 11,12-EET effects during amiloride treatment:
mucosal addition of amiloride (final concentration 10
4
M), data recording for 3 min, mucosal addition of 11,12-EET (final concentration 10
6 M), data recording for 3 min, then
addition of the remaining standard drugs. 5) 11,12-EET effects with
Na+ free mucosal medium: mucosal chamber filled with sodium
free solution (same formulation as KBR except sodium replaced with N-methyl-D-glutamine) and parameters monitored until steady
state obtained, mucosal addition of 11,12-EET (final concentration
10
6 M), data recording for 3 min, then addition of
standard drugs. 6) Bumetanide effects: submucosal addition of
bumetanide (final concentration 10
4 M), data recording
for 3 min, then addition of standard drugs. 7) 11,12-EET effects during
bumetanide treatment: submucosal addition of bumetanide (final
concentration 10
4 M), data recording for 3 min, mucosal
addition of 11,12-EET (final concentration 10
6 M), data
recording for 3 min, then addition of standard drugs.
Synthesis and purification of EETs and DHETs.
Racemic EETs
were prepared as previously described (Corey et al., 1980
;
Falck and Manna, 1982
). [1-14C]EETs were synthesized from
[1-14C]AA (55-57 µCi/µmol) by nonselective
epoxidation (Falck et al., 1990
). The enantiomers of
11,12-EET were prepared by total asymmetric synthesis according to
published procedures and by chiral phase high-performance liquid
chromatography separation of racemic 11,12-EET (Hammonds et
al., 1989
; Mosset et al., 1986
; Moustakis et
al., 1986
). DHETs and [1-14C]DHETs were prepared by
chemical hydration of individual EETs as described (Zeldin et
al., 1993
). Synthetic EETs, DHETs, and AA were purified by
reverse-phase high-performance liquid chromatography before use
(Capdevila et al., 1990
).
Statistical methods. Data from experiments with stable baseline voltage of more than 1 mV (127 of 151 preparations) were analyzed. All data were expressed as the mean ± S.E.M. Groups were compared using the t test for independent means; paired t tests were used when necessary.
| |
Results |
|---|
|
|
|---|
Intact Rat Tracheas
The intact rat tracheal studies were designed to evaluate the effects of P450-derived eicosanoids on airway epithelial cell electrophysiological parameters and to determine which compound(s) to investigate in the cultured rat tracheal epithelial cell experiments.
Baseline bioelectric properties and responses to standard
drugs.
Baseline values for Vt, Rt and Isc in intact rat tracheas
(n = 19) were
3.58 ± 0.36 mV, 49.0 ± 2.3 Ohm.cm2 and 71.6 ± 5.3 µA/cm2,
respectively (table 1). Addition of
amiloride, isoproterenol and ATP resulted in significant changes in
these parameters as illustrated in figure
1 and table 1. Amiloride resulted in a significant reduction in Vt and Isc, and a small but significant increase in Rt (table 1). The effects of amiloride were consistent with
inhibition of mucosal Na+ conductance (Willumsen and
Boucher, 1991
). Isoproterenol induced a moderate increase in Vt and Isc
with a slight reduction in Rt (table 1; fig. 1). These effects were
persistent and were consistent with an increase in mucosal
Cl
conductance via a cAMP-dependent channel (Boucher,
1994
). ATP induced a marked but transient increase in Vt and Isc with a
reduction in Rt (table 1; fig. 1). These effects were consistent with a further increase in mucosal Cl
conductance due to
activation of purinergic receptors (Knowles et al., 1991
).
Addition of ethanol to the mucosal solution to a final concentration of
0.5% (v/v) did not significantly change Vt but resulted in a small
increase in Rt and a parallel reduction in Isc (data not shown).
|
|
Effects of eicosanoids.
Compared to vehicle, 11,12-EET caused
a significant reduction in Vt and Isc (fig.
2), without additional changes in Rt. The electrophysiologic effects of 11,12-EET were dose-dependent (
Vt = 0.15 ± 0.02, 0.26 ± 0.05 and 0.38 ± 0.08 mV, at
10
8, 10
7 and 10
6 M,
respectively, P < .05;
Isc =
8.18 ± 3.04,
11.95 ± 3.22, and
16.95 ± 5.42 µA/cm2, at
10
8, 10
7 and 10
6 M,
respectively, P < .05). Addition of 11,12-DHET was associated with a smaller but significant reduction in Vt and Isc that reached statistical significance at concentrations of 10
6 M
(
Vt = 0.39 ± 0.12 mV;
Isc =
10.42 ± 2.21 µA/cm2 at 10
6 M, P < .05). Addition
of AA, 5,6-EET methyl ester, 8,9-EET, 14,15-EET, 5,6-DHET, 8,9-DHET and
14,15-DHET did not elicit consistent or significant changes in Vt, Rt
or Isc compared to vehicle alone. After addition of eicosanoids,
tissues appropriately responded to amiloride, isoproterenol and ATP
additions, indicating tissue integrity and responsiveness (fig. 2).
|
Cultured Rat Trachea Epithelial Cells
The results obtained with intact rat tracheas were further investigated using a cultured rat tracheal epithelial cell preparation.
Baseline bioelectric properties and responses to standard
drugs.
Baseline values for Vt, Rt and Isc in cultured tracheal
epithelial cells (n = 8) were
19.9 ± 8.6 mV,
148.4 ± 32.1 Ohm.cm2 and 122.0 ± 26.5 µA/cm2, respectively (table 1). Values of Vt and Rt were
higher in cultured epithelial cell sheets compared to intact tracheal
preparations, presumably because of edge damage in the intact tracheal
experiments. Addition of amiloride, isoproterenol and ATP caused
changes in Vt, Rt and Isc that were similar in magnitude and polarity
to the intact excised tracheal experiments (table 1; fig. 3), thus indicating that the responses observed in intact tracheas were primarily due to effects on epithelial cells. No significant changes in
Vt, Rt and Isc occurred over time (table
2). Addition of ethanol to the mucosal
side of cell inserts, to a final concentration of 0.08% (v/v) caused a
progressive decrease in Vt that reached statistical significance only
for the highest concentration (table 2). As was the case for intact
tracheas, ethanol caused a significant increase in Rt and a parallel
but statistically insignificant reduction in Isc (table 2).
|
Dose response effects of 11,12-EET.
Mucosal addition of
11,12-EET reproduced the effects observed in intact trachea studies
(fig. 3; table 2). Thus, compared to
vehicle alone, 11,12-EET caused a significant and dose-dependent decrease in Vt, a small but statistically insignificant reduction in
Isc, and no additional changes in Rt (table 2). The changes in Vt were
observed at concentrations as low as 10
9 M (table 2).
|
11,12-EET enantiomer studies.
To determine if the effects of
11,12-EET on tracheal epithelial cell electrophysiology were
stereoselective, we exposed cultured cells to either 11(R),12(S)-EET or
11(S),12(R)-EET. Mucosal addition of 11(R),12(S)-EET (final
concentration 10
6 M) induced marked reductions in Vt
similar to the effects observed after addition of racemic 11,12-EET
(fig. 4). In contrast, no significant
effects in Vt were noted after the addition of 11(S),12(R)-EET (final
concentration 10
6 M) (fig. 4). The effects of 11,12-EET,
11(R),12(S)-EET and 11(S),12(R)-EET on Isc were similar in magnitude
and direction to their effects on Vt.
|
11,12-EET mechanistic studies.
Mucosal addition of racemic
11,12-EET (final concentration 10
6 M) caused a
significant reduction compared to both time and vehicle controls (fig.
5). Pretreatment of the tissue with the
Na+ channel blocker amiloride did not significantly alter
the effects of 11,12-EET on Vt (fig. 5). Similarly, perfusion of the
mucosal chamber with sodium free media also failed to modify the
11,12-EET-induced effects on Vt (fig. 5). In contrast, perfusion of the
submucosal chamber with bumetanide (final concentration
10
4 M) abolished the 11,12-EET-induced changes in Vt
(fig. 5). The effects of 11,12-EET in the presence of amiloride, sodium
free media and bumetinide on Isc were similar in magnitude and
direction to their effects on Vt. Of note, bumetanide itself caused a
reduction in Isc and Vt and an increase in Rt. Furthermore, as
expected, the effects of isoproterenol and ATP were attenuated after
exposure of cells to bumetanide (data not shown). Taken together, these results suggest that the effects of 11,12-EET may be mediated through
inhibition of a chloride conducting pathway.
|
| |
Discussion |
|---|
|
|
|---|
Ion transport in the respiratory epithelium is important to
control the volume and composition of the epithelial surface liquid layer (Boucher, 1994
; Widdicombe et al., 1991
).
Na+ ions move continuously from the airway lumen to the
pulmonary interstitium through epithelial cells, although
Cl
ions follow, most probably through a paracellular
route (Willumsen et al., 1989
). Na+ is actively
secreted from the submucosal side of the cell membrane via the
Na+/K+-ATPase, thus creating a transcellular
electrochemical gradient that allows Na+ entry via
amiloride-sensitive Na+ channels (Willumsen and Boucher,
1991
). During basal conditions in human cells, there is little
transcellular movement of Cl
except for a small
Cl
influx through the mucosal membrane, primarily due to
a slight electrochemical imbalance. Less is known about the control of Cl
ion transport in non-human respiratory epithelium. In
the rabbit, Na+ channel blockade with amiloride causes
mucosal membrane hyperpolarization (and therefore reduction in the Vt).
Under these circumstances, mucosal Cl
secretion can be
demonstrated (Van Scott et al., 1989
). Several mechanisms
have been postulated to account for the mucosal Cl
conductance but at least two channels have been identified: 1) CFTR,
the cystic fibrosis transmembrane regulator, that is activated by
increases in intracellular cAMP (e.g., by exposure to
sympathetic
2-agonist agents) and 2) calcium sensitive
channels that are activated by intracellular surges of Ca++
(e.g., after exposure to agents such as histamine and
bradykinin). Recently, mucosal exposure to triphosphate nucleotides
such as ATP and UTP has also been demonstrated to stimulate
Cl
secretion through membrane triphosphate nucleotide
(P2Y2) receptors. It is not clear if these receptors activate
Ca++-sensitive channels or act through a distinct
Cl
channel (Knowles et al., 1991
).
The P450-derived eicosanoids are known to modulate ion transport in the
kidney, cornea, heart and vascular smooth muscle (Force et
al., 1991
; Harris et al., 1990
; Hu and Kim, 1993
;
Jacobson et al., 1984
; Kutsky et al., 1983
;
Madhun et al., 1991
; Malcolm and Fitzpatrick, 1992
;
Masferrer et al., 1990
; Moffat et al., 1993
;
Roman and Harder, 1993
). Among the effects observed were: 1) increase
in Ca++ permeability mediated through verapamil-sensitive
and voltage-sensitive channels (Madhum et al., 1991
; Snyder
et al., 1983
); 2) stimulation or inhibition of
Na+/K+-ATPase (Escalante et al.,
1988
; Masferrer et al., 1990
); 3) activation of
Na+/H+ exchange (Harris et al.,
1990
) and 4) activation or inhibition of Ca++-dependent
K+ channel (Hu and Kim, 1993
; Masferrer et al.,
1990
). These data suggest that the P450-derived AA metabolites might
also affect epithelial electrolyte transport in the airway. We
therefore examined the effects of synthetic, HPLC purified EETs, DHETs
and AA on transepithelial electrical parameters. In intact tracheas, of the compounds tested, only 11,12-EET and its corresponding diol, 11,12-DHET, caused significant, dose-dependent reductions in Vt and
Isc. Changes in electrical parameters induced by the other eicosanoids
were small, inconsistent and statistically insignificant; however, we
cannot rule out the possibility that these other eicosanoids may have
small but significant effects at higher concentrations, particularly if
tested in larger numbers of animals. The effects of 11,12-EET were
rapid and occurred at physiologically relevant concentrations
(10
8-10
6 M). Furthermore, these effects of
11,12-EET were reproduced in cultured tracheal epithelial cells
indicating that the responses observed in intact tracheas were
primarily epithelial mediated. The 11,12-EET inhibition of Vt is
smaller in magnitude than the stimulatory effects of isoproterenol and
ATP (figs. 2 and 3) suggesting that P450-derived AA metabolites may be
less important regulators of tracheal transepithelial ion transport. To
our knowledge, this is the first demonstration of a physiological
effect of AA epoxygenase metabolites on the airway epithelium.
Previous work has shown constitutive expression of a number of P450 AA
monooxygenases in the lung including members of the CYP1A, CYP2B, CYP2E
and CYP2J subfamilies (Domin et al., 1986
; Knickle and Bend,
1994
; Zeldin et al., 1995
, 1996
). Immunohistochemistry and
in situ hybridization have demonstrated that these
hemoproteins are highly expressed in Clara cells and present in much
lower levels in ciliated epithelial cells and goblet cells (Domin
et al., 1986
; Serabjit-Singh et al., 1980
, 1988
;
Strum et al., 1990
). Recently, our laboratory has shown that
members of the CYP2J subfamily are highly expressed in both ciliated
and nonciliated epithelial cells throughout the airway from trachea to
bronchioles (Zeldin et al., 1996
). We describe
electrophysiological effects of P450-derived AA metabolites in rat
trachea (which has both ciliated and nonciliated epithelial cells) and
in cultured rat tracheal epithelial cells. Future studies should
attempt to localize the effects of 11,12-EET to specific cell types
within the airway.
Isc has been demonstrated by radioisotope ion flow studies to correlate
well with net electrogenic transepithelial ion transport (Boucher,
1994
). Therefore, one would predict based on our studies, that
11,12-EET caused a reduction in net electrogenic transepithelial ion
transport. However, Isc measurements are not able to identify specific
ion currents. Therefore, studies were devised to elucidate the
mechanisms of action of 11,12-EET-induced changes in Isc. We presumed
that a reduction in Isc may be caused by one or more of the following:
1) reduction in Na+ inflow; 2) decrease in Cl
secretion and/or 3) general metabolic inhibition. To evaluate effects
on Na+ flux, we first blocked mucosal Na+
channels with amiloride and demonstrated that this manipulation did not
alter the electrical effects induced by 11,12-EET. Next we removed
Na+ from the mucosal bathing solution and showed that
eliminating mucosal inflow of Na+ had no effect on
11,12-EET-induced electrical changes. Based on these results, we
concluded that 11,12-EET did not affect mucosal amiloride-sensitive
Na+ channels and was not likely involved in Na+
transcellular ion flow. To study potential effects of 11,12-EET on
Cl
secretion, cells were exposed to bumetanide, a
submucosal membrane Na+/K+/Cl
cotransport inhibitor, to reduce intracellular Cl
availability for mucosal secretion. Bumetanide alone caused a significant reduction in Isc and loss in Vt, suggesting that, at
difference to humans (Boucher, 1994
) there was a basal secretion of
Cl
in rat tracheal epithelial cells that is impaired by
bumetanide. Importantly, pretreatment of cells with bumetanide
significantly reduced the effects of 11,12-EET on Vt and Isc, thus
suggesting that the mechanism of action of 11,12-EET may involve
inhibition of a Cl
conductive pathway. Previous work has
demonstrated that, at higher doses than those used in our study, AA
caused inhibition of mucosal Cl
secretion in the dog and
human airway (Hwang et al., 1990
; Mochizuki et
al., 1992
). Our findings suggest that the active compound may actually be a P450-derived metabolite of AA. In this regard, Kersting et al. (1993a
, b
) have demonstrated that the P450
epoxygenase inhibitor, ketoconazole, increases mucosal Cl
transport in gallbladder epithelial cells and activates
Cl
conductance in cultured cystic fibrosis cells.
Chloride conductance in airway epithelium depends on the stimulus and
multiple Cl
channels probably exist in airway epithelial
cells (Knowles et al., 1991
). The inhibitory effects of
11,12-EET on airway epithelial electrophysiological parameters may be
small in magnitude, in part because only one of several
Cl
channels are affected. Future studies should focus on
characterizing the effects of 11,12-EET on specific Cl
channels.
The most striking finding in our study was that the effects of
11,12-EET on airway epithelial electrophysiology were highly enantioselective. Thus, although 11(R),12(S)-EET was active in reducing
Vt and Isc, the opposite enantiomer 11(S),12(R)-EET was inactive. In
light of these findings, the possibility that 11,12-EET causes a
generalized nonspecific metabolic inhibition seems less likely. The
high degree of enantioselectivity of the 11,12-EET effects, together
with the fact that these actions occur in the nanomolar concentration
range, suggest the presence of specific receptors for the EETs (Wong
et al., 1993
). It is interesting that biologically active
11(R),12(S)-EET is also the least abundant rat lung enantiomer (Zeldin
et al., 1996
) suggesting that availability of the active
compound may be a limiting factor. Other biological actions of the
EETs, including cycloxygenase inhibition and renal vascular effects,
have been shown to be stereoselective (Fitzpatrick et al.,
1986
; Katoh et al., 1991
).
There are technical limitations to using Ussing chamber studies of
small tissues. When tissues are clamped in these chambers, edge damage
may occur and can lead to a pathway for ion and current leakage. As the
diameter of the orifice decreases, this becomes more of a problem
because the circumferential region of edge damage increases
disproportionately to the exposed surface area. The opening of the
chamber in our study is small (~7 mm2) by necessity
because rat tracheas have a relatively small circumference. Thus, it is
possible that edge damage may have occurred in our intact tracheal
experiments. However, accurate data can and have been obtained with
small tissues using careful techniques. For example, Grubb et
al. (1994)
reported a transepithelial resistance of 32 to 33 ohm.cm2 in intact mouse tracheas using techniques analogous
to ours. Importantly, our results with the intact tracheas were
confirmed in cultured cell preparations, where the experimental
preparation eliminates the possibility of edge damage.
In summary, we provide evidence that some P450-derived AA metabolites
cause significant and dose-dependent effects on airway epithelial cell
electrophysiology. The effects appear to be limited to one of the EET
regioisomers (11,12-EET) and are highly enantioselective for
11(R),12(S)-EET, the least abundant rat lung enantiomer. Furthermore, the EET-induced effects may be mediated through inhibition of a
Cl
conductive pathway. We conclude, based on these data,
that the AA epoxygenase metabolites are involved in the control of lung fluid/electrolyte transport. We speculate that altered local
concentration of these bioactive eicosanoids may contribute to lung
dysfunction.
| |
Acknowledgments |
|---|
The authors thank Drs. James Snapper, Tom Eling and Scott Randell for their helpful comments during the preparation of this manuscript.
| |
Footnotes |
|---|
Accepted for publication April 13, 1998.
Received for publication June 30, 1997.
1 This work was supported with federal funds from the National Institute of Environmental Health Sciences, National Institutes of Health, Contract NO1-ES-35357, and National Institutes of Health Grants DK46004 (J.R.Y.) and GM31278 (J.R.F.).
Send reprint requests to: Dr. Darryl C. Zeldin, Laboratory of Pulmonary Pathobiology, National Institutes of Health, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709.
| |
Abbreviations |
|---|
EET, epoxyeicosatrienoic acid; DHET, dihydroxyeicosatrienoic acid; AA, arachidonic acid; Vt, transepithelial voltage difference; Isc, equivalent short circuit current; Rt, tissue electrical resistance; RTE, rat tracheal epithelial cells; IET, intact excised trachea; CMS, collagen matrix support; FBS, fetal bovine serum; DMEM, Dulbecco's modified Eagle's medium; KBR, Krebs bicarbonate Ringer; PG, prostaglandin.
| |
References |
|---|
|
|
|---|
conductance and blocks Cl
and fluid absorption by cultured cystic fibrosis (CFPAC-1) cells.
Proc Natl Acad Sci USA
90:
4047-4051
transport across rabbit nonciliated bronchiolar epithelial (Clara) cells.
Am J Physiol
256 (Cell Physiol. 25):
C893-C901
activity and cellular Cl
pathways in cultured human airway epithelium.
Am J Physiol
256 (Cell Physiol. 25):
C1033-C1044This article has been cited by other articles:
![]() |
B. D. Przybyla-Zawislak, P. K. Srivastava, J. Vazquez-Matias, H. W. Mohrenweiser, J. E. Maxwell, B. D. Hammock, J. A. Bradbury, A. E. Enayetallah, D. C. Zeldin, and D. F. Grant Polymorphisms in Human Soluble Epoxide Hydrolase Mol. Pharmacol., August 1, 2003; 64(2): 482 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 39 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Jacobs and D. C. Zeldin The lung HETEs (and EETs) up Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney J. Biol. Chem., June 18, 1999; 274(25): 17777 - 17788. [Abstract] [Full Text] [PDF] |
||||